Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,565 | -80,288 | -51,655 | -21,968 | -114,432 |
| Depreciation Amortization | 1,265 | 802 | 568 | 293 | 925 |
| Accounts receivable | -1,359 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,215 | 245 | 2,112 | 3,692 | -4,022 |
| Other Working Capital | 17,937 | 2,292 | 1,138 | 3,348 | 6,320 |
| Other Operating Activity | 17,099 | 9,516 | 4,371 | -395 | 15,824 |
| Operating Cash Flow | $-75,408 | $-67,433 | $-43,466 | $-15,030 | $-95,385 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -103,082 | -49,182 | N/A | N/A | -55,285 |
| PPE Investments | -795 | -422 | -226 | N/A | -961 |
| Purchase Of Investment | 30,750 | 12,750 | 9,600 | 9,600 | 25,150 |
| Other Investing Activity | -15,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-88,127 | $-36,854 | $9,374 | $9,600 | $-31,096 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 23,709 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 48,451 | 71,255 | 13,785 | 2,132 | 102,377 |
| Other Financing Activity | 57,224 | 57,224 | 0 | 18 | 0 |
| Financing Cash Flow | $129,384 | $128,479 | $13,785 | $2,150 | $102,377 |
| Beginning Cash Position | 78,190 | 78,190 | 78,190 | 78,190 | 102,294 |
| End Cash Position | 44,039 | 102,382 | 57,883 | 74,910 | 78,190 |
| Net Cash Flow | $-34,151 | $24,192 | $-20,307 | $-3,280 | $-24,104 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,408 | -67,433 | -43,466 | -15,030 | -95,385 |
| Capital Expenditure | -795 | -422 | -226 | N/A | -961 |
| Free Cash Flow | -76,203 | -67,855 | -43,692 | -15,030 | -96,346 |